July 27, 2018 / 10:55 AM / 4 months ago

Merck's quarterly profit falls 12 pct

July 27 (Reuters) - Drugmaker Merck & Co reported a 12.3 percent fall in quarterly profit on Friday, as research and development expenses rose.

Net income attributable to the company fell to $1.71 billion, or 63 cents per share, in the second quarter, from $1.95 billion, or 71 cents per share, a year earlier.

Sales of its blockbuster cancer drug Keytruda rose 89.2 percent to $1.67 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below